Skip to main content
Erschienen in: World Journal of Surgery 5/2018

26.10.2017 | Original Scientific Report

Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1

verfasst von: V. Polenta, E. P. Slater, P. H. Kann, M. B. Albers, J. Manoharan, A. Ramaswamy, A. H. Mahnken, D. K. Bartsch

Erschienen in: World Journal of Surgery | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Radiological tumor size of non-functioning pancreatic neuroendocrine neoplasms (Nf-pNENs) associated with multiple endocrine neoplasia type 1 (MEN1) is a crucial parameter to indicate surgery. The aim of this study was to compare radiological size (RS) and pathologic size (PS) of MEN1 associated with pNENs.

Methods

Prospectively collected data of MEN1 patients who underwent pancreatic resections for pNENs were retrospectively analyzed. RS was defined as the largest tumor diameter measured on endoscopic ultrasound (EUS), magnetic resonance imaging (MRI) or computed tomography (CT). PS was defined as the largest tumor diameter on pathological analysis. Student’s t test and linear regression analysis were used to compare the median RS and PS. p < 0.05 was considered significant.

Results

Forty-four patients with a median age of 37 (range 10–68) years underwent primary pancreatic resections for pNENs. Overall, the median RS (20 mm, range 3–100 mm) was significantly larger than the PS (13 mm, range 4–110 mm) (p = 0.001). In patients with pNENs < 20 mm (n = 27), the size difference (median RS 15 mm vs PS 12 mm) was also significant (p = 0.003). However, the only modality that significantly overestimated the PS was EUS (median RS 14 mm vs 11 mm; p = 0.0002). RS overestimated the PS in 21 patients (21 of 27 patients, 78%). Five of 11 patients (12%) with a Nf-pNEN and a RS > 20 mm had in reality a PS < 20 mm. MRI was the imaging technique that best correlated with PS in the total cohort (r = 0.8; p < 0.0001), whereas EUS was the best correlating imaging tool in pNENs < 20 mm (r = 0.5; p = 0.0001).

Conclusion

Preoperative imaging, especially EUS, frequently overestimates the size of MEN1-pNENs, especially those with a PS < 20 mm. This should be considered when indicating surgery in MEN1 patients with small Nf-pNENs.
Literatur
1.
2.
Zurück zum Zitat Trump D, Farren B, Wooding C et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 89(9):653–669CrossRefPubMed Trump D, Farren B, Wooding C et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 89(9):653–669CrossRefPubMed
3.
Zurück zum Zitat Marx S, Spiegel AM, Skarulis MC et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129(6):484–494CrossRefPubMed Marx S, Spiegel AM, Skarulis MC et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129(6):484–494CrossRefPubMed
4.
Zurück zum Zitat Carney JA (2005) Familial multiple endocrine neoplasia: the first 100 years. Am J Sur Pathol 29(2):254–274CrossRef Carney JA (2005) Familial multiple endocrine neoplasia: the first 100 years. Am J Sur Pathol 29(2):254–274CrossRef
6.
Zurück zum Zitat Chandrasekharappa SC, Guru SC, Manickam P et al (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276(5311):404–407CrossRefPubMed Chandrasekharappa SC, Guru SC, Manickam P et al (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276(5311):404–407CrossRefPubMed
7.
Zurück zum Zitat Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990–3011CrossRefPubMed Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990–3011CrossRefPubMed
8.
Zurück zum Zitat Tonelli F, Giudici F, Giusti F et al (2012) Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Cancers 4(2):504–522CrossRefPubMedPubMedCentral Tonelli F, Giudici F, Giusti F et al (2012) Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Cancers 4(2):504–522CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Thomas-Marques L, Murat A, Delemer B et al (2006) Prospective endoscopic ultrasonographic evaluation of the frequency of non functioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 101:266–273CrossRefPubMed Thomas-Marques L, Murat A, Delemer B et al (2006) Prospective endoscopic ultrasonographic evaluation of the frequency of non functioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 101:266–273CrossRefPubMed
11.
Zurück zum Zitat Carty SE, Helm AK, Amico JA et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124(6):1106–1113CrossRefPubMed Carty SE, Helm AK, Amico JA et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124(6):1106–1113CrossRefPubMed
12.
Zurück zum Zitat Triponez F, Dosseh D, Goudet P et al (2006) Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 243(2):265–272CrossRefPubMedPubMedCentral Triponez F, Dosseh D, Goudet P et al (2006) Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 243(2):265–272CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Goudet P, Murat A, Binquet C et al (2010) Risk factors and causes of death in MEN1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 34(2):249–255. doi:10.1007/s00268-009-0290-1 CrossRefPubMed Goudet P, Murat A, Binquet C et al (2010) Risk factors and causes of death in MEN1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 34(2):249–255. doi:10.​1007/​s00268-009-0290-1 CrossRefPubMed
14.
Zurück zum Zitat Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103(2):153–171CrossRefPubMedPubMedCentral Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103(2):153–171CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Vinik AI, Woltering EA, Warner RR et al (2010) NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 39(6):713–734CrossRefPubMed Vinik AI, Woltering EA, Warner RR et al (2010) NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 39(6):713–734CrossRefPubMed
16.
Zurück zum Zitat Partelli S, Tamburrino D, Lopez C et al (2016) Active surveillance versus surgery of nonfunctioning pancreatic neuroendocrine neoplasms ≤2 cm in MEN1 patients. Neuroendocrinology 103(6):779–786CrossRefPubMed Partelli S, Tamburrino D, Lopez C et al (2016) Active surveillance versus surgery of nonfunctioning pancreatic neuroendocrine neoplasms ≤2 cm in MEN1 patients. Neuroendocrinology 103(6):779–786CrossRefPubMed
17.
Zurück zum Zitat Baur AD, Pavel M, Prasad V et al (2016) Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment. Acta Radiol Open 57(3):260–270CrossRef Baur AD, Pavel M, Prasad V et al (2016) Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment. Acta Radiol Open 57(3):260–270CrossRef
18.
Zurück zum Zitat Kann P, Bittinger F, Engelbach M et al (2001) Endosonography of insulin-secreting and clinically non-functioning neuroendocrine tumors of the pancreas: criteria for benignancy and malignancy. Eur J Med Res 6(9):385–390PubMed Kann P, Bittinger F, Engelbach M et al (2001) Endosonography of insulin-secreting and clinically non-functioning neuroendocrine tumors of the pancreas: criteria for benignancy and malignancy. Eur J Med Res 6(9):385–390PubMed
19.
Zurück zum Zitat Kann PH, Wirkus B, Keth A et al (2003) Pitfalls in endosonographic imaging of suspected insulinomas: pancreatic nodules of unknown dignity. Eur J Endocrinol 148(5):531–534CrossRefPubMed Kann PH, Wirkus B, Keth A et al (2003) Pitfalls in endosonographic imaging of suspected insulinomas: pancreatic nodules of unknown dignity. Eur J Endocrinol 148(5):531–534CrossRefPubMed
20.
Zurück zum Zitat Kann PH, Balakina E, Ivan D et al (2006) Natural course of small, asymptomatic neuroendocrine pancreatic tumors in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Endocr Relat Cancer 13(4):1195–1202CrossRefPubMed Kann PH, Balakina E, Ivan D et al (2006) Natural course of small, asymptomatic neuroendocrine pancreatic tumors in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Endocr Relat Cancer 13(4):1195–1202CrossRefPubMed
21.
Zurück zum Zitat Kann PH, Kann B, Fassbender WJ et al (2006) Small neuroendocrine pancreatic tumors in multiple endocrine neoplasia type 1 (MEN1): least significant change of tumor diameter as determined by endoscopic ultrasound (EUS) imaging. Exp Clin Endocrinol Diabetes 114(7):361–365CrossRefPubMed Kann PH, Kann B, Fassbender WJ et al (2006) Small neuroendocrine pancreatic tumors in multiple endocrine neoplasia type 1 (MEN1): least significant change of tumor diameter as determined by endoscopic ultrasound (EUS) imaging. Exp Clin Endocrinol Diabetes 114(7):361–365CrossRefPubMed
22.
Zurück zum Zitat Bartsch DK, Slater EP, Albers MB et al (2014) Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain. J Clin Endocrinol Metab 99(11):2387–2391CrossRef Bartsch DK, Slater EP, Albers MB et al (2014) Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain. J Clin Endocrinol Metab 99(11):2387–2391CrossRef
23.
Zurück zum Zitat Crippa S, Bassi C, Salvia R et al (2007) Enucleation of pancreatic neoplasms. Br J Surg 94(10):1254–1259CrossRefPubMed Crippa S, Bassi C, Salvia R et al (2007) Enucleation of pancreatic neoplasms. Br J Surg 94(10):1254–1259CrossRefPubMed
24.
Zurück zum Zitat Klöppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13–27CrossRefPubMed Klöppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13–27CrossRefPubMed
26.
Zurück zum Zitat Irani J, Humbert M, Lecocq B et al (2001) Renal tumor size: comparison between computed tomography and surgical measurements. Eur Urol 39(3):300–303CrossRefPubMed Irani J, Humbert M, Lecocq B et al (2001) Renal tumor size: comparison between computed tomography and surgical measurements. Eur Urol 39(3):300–303CrossRefPubMed
27.
Zurück zum Zitat Kelsey CR, Schefter T, Nash SR et al (2005) Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. Am J Clin Oncol 28(6):576–580CrossRefPubMed Kelsey CR, Schefter T, Nash SR et al (2005) Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. Am J Clin Oncol 28(6):576–580CrossRefPubMed
29.
Zurück zum Zitat Triponez F, Goudet P, Dosseh D et al (2006) Is surgery beneficial for MEN 1 patients with small (<2 cm), non-functioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from GTE. World J Surg 30(5):654–662. doi:10.1007/s00268-005-0354-9 CrossRefPubMed Triponez F, Goudet P, Dosseh D et al (2006) Is surgery beneficial for MEN 1 patients with small (<2 cm), non-functioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from GTE. World J Surg 30(5):654–662. doi:10.​1007/​s00268-005-0354-9 CrossRefPubMed
30.
Zurück zum Zitat Norton JA, Fraker DL, Alexander HR et al (1999) Surgery to cure the Zollinger–Ellison syndrome. N Engl J Med 341(9):635–644CrossRefPubMed Norton JA, Fraker DL, Alexander HR et al (1999) Surgery to cure the Zollinger–Ellison syndrome. N Engl J Med 341(9):635–644CrossRefPubMed
31.
Zurück zum Zitat Norton JA (2005) Surgical treatment and prognosis of gastrinoma. Best Pract Res Clin Gastroenterol 19(5):799–805CrossRefPubMed Norton JA (2005) Surgical treatment and prognosis of gastrinoma. Best Pract Res Clin Gastroenterol 19(5):799–805CrossRefPubMed
32.
33.
Zurück zum Zitat Skogseid B, Eriksson B, Lundgvist G et al (1991) Multiple endocrine neoplasia type 1: a 10 years prospective screening study in four kindreds. J Clin Endocrinol Metab 73(2):281–287CrossRefPubMed Skogseid B, Eriksson B, Lundgvist G et al (1991) Multiple endocrine neoplasia type 1: a 10 years prospective screening study in four kindreds. J Clin Endocrinol Metab 73(2):281–287CrossRefPubMed
34.
Zurück zum Zitat Bartsch DK, Langer P, Wild A et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128(6):958–966CrossRefPubMed Bartsch DK, Langer P, Wild A et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128(6):958–966CrossRefPubMed
35.
Zurück zum Zitat Morrow EH, Norton JA (2009) Surgical management of Zollinger-Ellison syndrome; state of the art. Surg Clin North Am 89(5):1091–1103CrossRefPubMed Morrow EH, Norton JA (2009) Surgical management of Zollinger-Ellison syndrome; state of the art. Surg Clin North Am 89(5):1091–1103CrossRefPubMed
37.
Zurück zum Zitat You YN, Thompson GB, Young WF Jr et al (2007) Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: operative outcomes, long-termfunction, and quality of life. Surgery 142(6):829–836CrossRefPubMed You YN, Thompson GB, Young WF Jr et al (2007) Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: operative outcomes, long-termfunction, and quality of life. Surgery 142(6):829–836CrossRefPubMed
38.
Zurück zum Zitat Gauger PG, Scheiman JM, Wamsteker EJ et al (2003) Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 90(6):748–754CrossRefPubMed Gauger PG, Scheiman JM, Wamsteker EJ et al (2003) Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 90(6):748–754CrossRefPubMed
39.
Zurück zum Zitat Langer P, Kann PH, Fendrich V et al (2004) Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumours (PETs) in patients with multiple endocrine neoplasia type 1 (MEN 1). World J Surg 28(12):1317–1322. doi:10.1007/s00268-004-7642-7 CrossRefPubMed Langer P, Kann PH, Fendrich V et al (2004) Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumours (PETs) in patients with multiple endocrine neoplasia type 1 (MEN 1). World J Surg 28(12):1317–1322. doi:10.​1007/​s00268-004-7642-7 CrossRefPubMed
40.
Zurück zum Zitat Van Asselt SJ, Brouwers AH, van Dullemen HM et al (2015) EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1. Gastrointest Endosc 81(1):159–167CrossRefPubMed Van Asselt SJ, Brouwers AH, van Dullemen HM et al (2015) EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1. Gastrointest Endosc 81(1):159–167CrossRefPubMed
41.
42.
Zurück zum Zitat Haraldsdòttir KH, Jònsson P, Halldòrsdòttir AB et al (2017) Tumor size of invasive breast cancer on magnetic resonance imaging and conventional imaging (mammogram/ultrasound): comparison with pathological size and clinical implications. Scand J Surg 106(1):68–73CrossRefPubMed Haraldsdòttir KH, Jònsson P, Halldòrsdòttir AB et al (2017) Tumor size of invasive breast cancer on magnetic resonance imaging and conventional imaging (mammogram/ultrasound): comparison with pathological size and clinical implications. Scand J Surg 106(1):68–73CrossRefPubMed
Metadaten
Titel
Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1
verfasst von
V. Polenta
E. P. Slater
P. H. Kann
M. B. Albers
J. Manoharan
A. Ramaswamy
A. H. Mahnken
D. K. Bartsch
Publikationsdatum
26.10.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 5/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4317-8

Weitere Artikel der Ausgabe 5/2018

World Journal of Surgery 5/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.